SI1000063T1 - 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO(4,5-b)INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY - Google Patents

4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO(4,5-b)INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY

Info

Publication number
SI1000063T1
SI1000063T1 SI9830309T SI9830309T SI1000063T1 SI 1000063 T1 SI1000063 T1 SI 1000063T1 SI 9830309 T SI9830309 T SI 9830309T SI 9830309 T SI9830309 T SI 9830309T SI 1000063 T1 SI1000063 T1 SI 1000063T1
Authority
SI
Slovenia
Prior art keywords
pyridazino
indole
dihydro
oxo
therapy
Prior art date
Application number
SI9830309T
Other languages
English (en)
Slovenian (sl)
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
Regine Bartsch
Catherine Gille
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SI1000063T1 publication Critical patent/SI1000063T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
SI9830309T 1997-07-30 1998-07-28 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO(4,5-b)INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SI1000063T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EP98941468A EP1000063B1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
SI1000063T1 true SI1000063T1 (en) 2003-04-30

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830309T SI1000063T1 (en) 1997-07-30 1998-07-28 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO(4,5-b)INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY

Country Status (33)

Country Link
US (1) US6262045B1 (xx)
EP (1) EP1000063B1 (xx)
JP (1) JP4322421B2 (xx)
KR (1) KR100497782B1 (xx)
CN (1) CN1134440C (xx)
AR (1) AR013264A1 (xx)
AT (1) ATE226584T1 (xx)
AU (1) AU736600B2 (xx)
BG (1) BG64283B1 (xx)
BR (1) BR9811582B1 (xx)
CA (1) CA2298522C (xx)
CO (1) CO5210883A1 (xx)
CZ (1) CZ290011B6 (xx)
DE (1) DE69808921T2 (xx)
DK (1) DK1000063T3 (xx)
EE (1) EE04317B1 (xx)
ES (1) ES2186212T3 (xx)
FR (1) FR2766823B1 (xx)
HK (1) HK1028027A1 (xx)
HU (1) HU229430B1 (xx)
IL (1) IL133633A (xx)
NO (1) NO313963B1 (xx)
NZ (1) NZ502361A (xx)
PL (1) PL194245B1 (xx)
PT (1) PT1000063E (xx)
RU (1) RU2197490C2 (xx)
SI (1) SI1000063T1 (xx)
SK (1) SK283075B6 (xx)
TR (1) TR200000278T2 (xx)
TW (1) TW506971B (xx)
UA (1) UA57088C2 (xx)
WO (1) WO1999006406A1 (xx)
ZA (1) ZA986786B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
GB0000564D0 (en) 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
WO2007086911A2 (en) * 2005-05-05 2007-08-02 Sanofi-Aventis U.S. Llc Stable nanoparticle formulations
CA2619438A1 (en) * 2005-08-29 2007-03-08 Irwin C. Jacobs Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino(4,5-b) indole-1-acetamide
ATE531717T1 (de) * 2005-08-29 2011-11-15 Sanofi Aventis Us Llc Neue kristalline form eines pyridazinoä4,5- büindolderivats
US7482360B2 (en) * 2005-09-23 2009-01-27 Schering Corporation Fused tetracyclic mGluR1 antagonists as therapeutic agents
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
RU2011110241A (ru) * 2008-08-18 2012-09-27 САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи (US) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОРФА 7-ХЛОР-N,N,5-ТРИМЕТИЛ-4-ОКСО-3-ФЕНИЛ-3,5-ДИГИДРО-4Н-ПИРИДАЗИНО[4,5-b]ИНДОЛ-1-АЦЕТАМИДА
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
BG104096A (en) 2000-08-31
KR20010022356A (ko) 2001-03-15
CZ290011B6 (cs) 2002-05-15
HUP0002650A3 (en) 2002-09-30
BR9811582B1 (pt) 2010-10-19
EE04317B1 (et) 2004-06-15
UA57088C2 (uk) 2003-06-16
FR2766823B1 (fr) 1999-10-08
CA2298522A1 (en) 1999-02-11
PL338445A1 (en) 2000-11-06
WO1999006406A1 (fr) 1999-02-11
CA2298522C (en) 2008-07-15
EE200000056A (et) 2000-10-16
ZA986786B (en) 1999-02-02
JP4322421B2 (ja) 2009-09-02
EP1000063A1 (fr) 2000-05-17
AU736600B2 (en) 2001-08-02
HUP0002650A2 (hu) 2001-01-29
NO313963B1 (no) 2003-01-06
CN1134440C (zh) 2004-01-14
DE69808921D1 (de) 2002-11-28
AU8983298A (en) 1999-02-22
IL133633A0 (en) 2001-04-30
BR9811582A (pt) 2000-09-26
PL194245B1 (pl) 2007-05-31
AR013264A1 (es) 2000-12-13
DE69808921T2 (de) 2003-07-03
NO20000462D0 (no) 2000-01-28
CZ2000320A3 (cs) 2000-05-17
PT1000063E (pt) 2003-03-31
ES2186212T3 (es) 2003-05-01
CN1265108A (zh) 2000-08-30
DK1000063T3 (da) 2003-02-24
SK283075B6 (sk) 2003-02-04
ATE226584T1 (de) 2002-11-15
TR200000278T2 (tr) 2000-08-21
FR2766823A1 (fr) 1999-02-05
IL133633A (en) 2004-02-08
US6262045B1 (en) 2001-07-17
NO20000462L (no) 2000-03-29
HK1028027A1 (en) 2001-02-02
JP2001512122A (ja) 2001-08-21
HU229430B1 (en) 2013-12-30
NZ502361A (en) 2001-06-29
EP1000063B1 (fr) 2002-10-23
KR100497782B1 (ko) 2005-06-27
CO5210883A1 (es) 2002-10-30
TW506971B (en) 2002-10-21
BG64283B1 (bg) 2004-08-31
RU2197490C2 (ru) 2003-01-27
SK1292000A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
AP2000001753A0 (en) 2,3-Diaryl-pyrazolo (1,5-b) pyridazines derivatives their preparation and their use as cycooxygenase 2(cox-2) inhibitors
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
SI1000063T1 (en) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO(4,5-b)INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
HUP9904206A3 (en) 1,4-diazabicyclo[2.2.2.]oct-2-ylmethyl derivatives,their preparation and therapeutic application
IL118644A (en) N-¬(1,4-diazabicyclo¬2.2.2¾oct-2-YL)methyl¾benzamide derivatives their preparation and their application in therapeutics
IL131645A (en) Pyrimido ¬1,2-a¾indole derivatives and their preparation
AU734696B2 (en) Novel carboxylic acid derivatives, their preparation and use in treating cancer
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
IL131254A0 (en) 2,3-Dihydrofuro ¬3,2-b¾ pyridin preparation and application thereof in therapy
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
ZA983740B (en) Novel amidine derivatives and their use in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.
ZA953749B (en) 5,6-dihydro-4H-thieno[3,4-c] pyrroie derivatives their preparation and their therapeutic application
AU6924198A (en) Benzenesulphonamide derivatives, preparation and application thereof in therapy
AU710380C (en) 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses